A detailed history of Creative Planning transactions in Moderna, Inc. stock. As of the latest transaction made, Creative Planning holds 45,421 shares of MRNA stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,421
Previous 54,015 15.91%
Holding current value
$1.79 Million
Previous $6.41 Million 52.68%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$63.64 - $125.14 $546,922 - $1.08 Million
-8,594 Reduced 15.91%
45,421 $3.04 Million
Q2 2024

Aug 15, 2024

SELL
$101.21 - $166.61 $297,962 - $490,499
-2,944 Reduced 5.17%
54,015 $6.41 Million
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $751,597 - $1.02 Million
8,804 Added 18.28%
56,959 $6.07 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $2.09 Million - $3.13 Million
-30,017 Reduced 38.4%
48,155 $4.79 Million
Q3 2023

Nov 16, 2023

BUY
$96.41 - $126.61 $3.77 Million - $4.95 Million
39,072 Added 99.93%
78,172 $8.07 Million
Q2 2023

Jul 21, 2023

SELL
$118.5 - $160.53 $625,087 - $846,795
-5,275 Reduced 11.89%
39,100 $4.75 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $772,583 - $1.12 Million
-5,695 Reduced 11.37%
44,375 $6.82 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $688,498 - $1.22 Million
-5,816 Reduced 10.41%
50,070 $8.99 Million
Q3 2022

Nov 03, 2022

SELL
$118.07 - $194.18 $366,489 - $602,734
-3,104 Reduced 5.26%
55,886 $6.61 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $949,104 - $1.43 Million
8,103 Added 15.92%
58,990 $8.43 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $2.04 Million - $3.79 Million
16,104 Added 46.3%
50,887 $8.77 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $16,484 - $26,901
73 Added 0.21%
34,783 $8.83 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $4.13 Million - $9.01 Million
18,593 Added 115.36%
34,710 $13.4 Million
Q2 2021

Aug 04, 2021

SELL
$129.91 - $234.98 $4.67 Million - $8.44 Million
-35,923 Reduced 69.03%
16,117 $3.79 Million
Q1 2021

Apr 30, 2021

SELL
$109.18 - $185.98 $575,815 - $980,858
-5,274 Reduced 9.2%
52,040 $6.82 Million
Q4 2020

Jan 29, 2021

BUY
$65.74 - $169.86 $630,841 - $1.63 Million
9,596 Added 20.11%
57,314 $5.99 Million
Q3 2020

Nov 05, 2020

BUY
$54.34 - $94.85 $63,849 - $111,448
1,175 Added 2.52%
47,718 $3.38 Million
Q2 2020

Jul 23, 2020

SELL
$29.67 - $80.0 $54,978 - $148,240
-1,853 Reduced 3.83%
46,543 $2.99 Million
Q1 2020

May 05, 2020

BUY
$17.78 - $31.58 $860,480 - $1.53 Million
48,396 New
48,396 $1.45 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.